Sleeve gastrectomy is a restrictive surgery that is effective as a single procedure in patients with body mass index (BMI) > 40 or co-morbid patients with BMI > 35 (13, 14). Fundus resection or sub-sleeve gastrectomy is a new experimental technique that its effectiveness in improving weight and comorbidities has not yet been extensively characterized. Our study indicate the rabbits to represent sleeve gastrectomy and fundus resection procedures in order to investigate the endocrine alternations and weight loss induced by surgery. In our results, similar to previous reports, rabbits undergoing sleeve gastrectomy showed a significant decrease in the body weight after one month when compared with sham-operated control animals and fundectomized rabbits, suggesting that weight loss was more effective in this group (
Table 1). This reduction could be related to the extension area of resection more than the reduction of ghrelin and leptin in sleeve gastrectomy. There was a significant decrease in the leptin levels in the fundectomy group (
Table 2).
Based on previous studies, sleeve gastrectomy decreased the leptin and ghrelin levels (
13-
15). Plasma ghrelin levels usually had increased in body mass index (
16). On the other hand, sleeve and sub-sleeve surgeries resected the gastric fundus, which secret the main amount of ghrelin (
12). In one study in gastrectomized mice replacement of ghrelin reversed the weight loss and increased body fat (
17). In another study about obese dogs, the plasma level of leptin and ghrelin was measured after a special diet due to weight loss. The ghrelin level lowered, and the leptin level became higher in comparison to normal-weight dogs, and the low-calorie diet made a decrease in the leptin level, but there was no change in the ghrelin level (
18). However, in some studies like ours, there were variable changes in plasma ghrelin levels following sleeve gastrectomy and fundus resection (
19). In another study, only in the first six postoperative months ghrelin levels were decreased after sleeve gastrectomy and after that did not have change significantly (
12). In obese, leptin-resistant Zucker rats, ghrelin levels were unchanged 14 days after sleeve gastrectomy and weight loss after surgery did not show any correlation with ghrelin level (
20). Also, in our investigation, total plasma ghrelin levels were not significantly different from the controls after the surgery as well. It suggested that weight loss after one month induced by sleeve gastrectomy is not dependent on ghrelin secretion. Other hypotheses indicate a compensatory increase in ghrelin secretion with other parts of the stomach in rabbits or by extra gastric ghrelin sources (
21). Sectioning of the vagus nerve in surgical technique, may also contribute to changes in ghrelin secretion, because the rabbits which underwent sleeve gastrectomy did not show any difference in the leptin levels, opposite to previous studies (
13,
22). In one study, rats that underwent sleeve gastrectomy significantly reduced their food intake in response to leptin. Basically, the leptin’s effects on controlling food intake were mediated by the hypothalamic melanocortin pathway but they did not find any evidence for increased activity of the leptin-melanocortin axis after sleeve gastrectomy (
22). In our study, the weight of rabbits after fundus resection did not change significantly and fundus resection seems to be inefficient as sleeve gastrectomy but it reduced leptin level significantly after 3 months (P = 0.025). In this regards, fundectomy could be suggested as a new option in metabolic disorders due to the high level of leptin, and the ability of sleeve gastrectomy to result in weight loss is based on some other effect rather than endocrine hormones. Finding out these effects will provide important insights into a new aspect of both surgical and non-surgical, could be designed.